Combination of erythropoietin and thalidomide for the treatment of anemia in patients with myelodysplastic syndromes
To access this article, please choose from the options below
PII: S0145-2126(05)00330-9
doi:10.1016/j.leukres.2005.08.020
© 2005 Elsevier Ltd. All rights reserved.
